Open original FDA record ↗Recall record
- FDA identifier
- Z-1518-2025
- Company in FDA record
- BioFire Diagnostics, LLC
- FDA classification date
- Apr 4, 2025
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Increased risk of control failures and false negative test results with multiplexed nucleic acid test.
Source facts
- Action
- On February 28, 2025, Biomerieux issued an "Urgent Field Safety Notice" Recall notification to affected consignees via email. The notice described the product, problem and actions to be taken. Biomerieux asked consignees to take the following actions: " Immediately examine your inventory for the lot identified in this field safety notice. " Discontinue use and discard any remaining product from this lot in your possession. bioMrieux will replace the product at no charge in accordance with our standard limited warranty. " Confirm the amount of pouches scrapped (if any) on the attached Acknowledgement of Receipt Form. " If you have further distributed this product, please identify any recipients and notify them at once. " Please complete the accompanying Acknowledgement of Receipt Form and return to bioMrieux so that bioMrieux may acknowledge your receipt of this notification. If you require additional assistance or have any questions, please contact your local bioMrieux Customer Service representative or call customer service department at 1-800-736-6354.
- Initiated
- 2025-02-27
- Root cause
- Nonconforming Material/Component
- Distribution
- OUS International Distribution to countries of: France, Italia, Spain, Switzerland, Israel
- Recall number
- Z-1518-2025
- Recall status
- Open, Classified
- CDRH record ID
- 212805
- FDA classified
- 2025-04-04
- Recall event number
- 96346